Contours and seamlessly adapts to tissue bed for optimal coverage.
Tissue Repair
Revolutionizing Reconstruction Through Regeneration
A new era in regenerative wound care, bridging advanced collagen biology with clinically validated tissue repair.
Ten Minute Tissue™
A Breakthrough Approach in Tissue Engineering.
Our Vision
“We envision a world where tissue repair is regenerative, not synthetic — accelerating healing and reducing scarring through natural biology.”
Best-in-Class Skin Substitute
Grounded in industry-leading collagen research and supporting multiple advanced product pipelines.
Proprietary Platform
Developed over years of rigorous R&D and steered by a seasoned executive team driving breakthroughs in regenerative medicine.
Innovative Tissue Regenaration
Cutting-edge, collagen-based approach enabling effective, on-demand tissue repair and aesthetic solutions.
Patented Technology
It takes ten minutes to deliver superior wound coverage, structural support, and tissue regeneration.
Conexeu’s patented collagen scaffold technology introduces a breakthrough in wound healing and reconstructive medicine. Ten Minute Tissue™ is a liquid dermal matrix engineered to mimic the body’s natural extracellular matrix (ECM), setting in place in approximately 10 minutes.
The Science
How It Works
A biomimetic, in situ-forming skin substitute designed to restore soft tissue structure and integrity.
CXU: How it Works
Gels in about ~10 minutes enabling precise placement and contouring.
Transitions from liquid to gel at 34°C, enhancing control during application and allowing accurate contouring to the wound.
Stays liquid at room temperature for easy injection and precise placement.
Gels quickly at body temperature to prevent migration and ensure targeted volumization.
CXU is an investigational device. Limited by federal (U.S.) law to investigational use. Safety and effectiveness have not been established.
Ten Minute Tissue™
Optimized for Tissue Integration
+ Rapid In-Situ Gelation: A liquid scaffold sets into a gel in roughly ten (10) minutes.
+ Integration Optimization: Designed to flow into the tissue for better integration.
+ Skin-Temperature Activation: Thermo-responsive — begins gelling at approximately 34 °C, (body temperature).
+ Preclinical Cell Remodeling: In animal models, cells thrive and remodel the matrix into native tissue.
+ Tissue : Once set, the scaffold is engineered to model the mechanical properties of human ECM.
+ Wound-Repair Evidence: Preclinical flap and mesh-graft studies demonstrate accelerated closure with minimal inflammation.
+ Multi-Indication Pipeline: Under investigation for tissue reconstruction, acute wounds, burns, skin ulcers, and future aesthetic applications.
CXU is an investigational device. Limited by federal (U.S.) law to investigational use. Safety and effectiveness have not been established.
Tissue Repair
Building New Tissue — Faster and Naturally
Conexeu’s unique approach is unlocking the regenerative potential of collagen through a patented, next-generation extracellular matrix scaffold.
New Tissue in ~10 Minutes
Drawing on more than a decade of research, CXU’s “Ten Minute Tissue™ supports the body’s natural healing process and soft tissue regeneration without the need for synthetic implants or inflammatory triggers.
Safe, Ready to Use, and Clinically Validated
Ten Minute Tissue™ is formulated to be non-toxic, non-fibrotic, and easy to deploy — a rapid, reliable solution for trauma, burns, surgical wounds, and soft tissue reconstruction.
Uniform Coverage & Seamless Integration
The liquid formulation ensures full coverage of any wound bed, contouring to irregular wound margins and depths.
Once set in place, the scaffold integrates naturally with the surrounding tissue, supporting cell migration and new tissue formation.
product summary
CXU is an investigational, patented, injectable extracellular matrix (ECM) scaffold designed to support rapid wound repair and tissue integration — in preclinical models it forms a supportive matrix in approximately ten minutes.
Performance
Accelerates wound closure up to 270% faster than untreated controls during the first 7 days, and achieved complete closure 250% sooner* in animal studies.
Accelerates wound closure up to 270% faster than untreated controls during the first 7 days, and achieved complete closure 250% sooner* in animal studies.
Clinically Validated
Accelerates healing up to 2.5x faster than market standards.
Adaptable Applications
Aesthetics, wound care, and major reconstructive surgeries—all under one platform.
Cost-Effective
Streamlined production for large-scale deployment.
Tissue Repair Applications
Countouring and filling volume deficits following lumpectomy or partial mastectomy.
Addressing asymmetry or deformities in the breast, chest wall, or other areas where volume supplementation is required.
Supplementing flap or implant-based reconstructions for contour stability and improved tissue regeneration.
Complex or extensive surface wounds needing a regenerative scaffold to enhance healing quality and tissue regeneration.
Large-area or complicated burns (thermal or chemical) that may benefit from ECM-based coverage or volumetric repair.
Sub-dermal volume loss resulting from accidents, excisional surgeries, or other significant tissue damage.
CXU is an investigational device. Limited by federal (U.S.) law to investigational use. Safety and effectiveness have not been established.
Our Products
Other Product Pipeline
Connexeu Labs
Innovation at the Heart of Regenartion
Redefining medical aesthetics with advanced biostimulatory collagen treatments.
Medical Aesthetics
Patented Collagen Scaffold Technology
Redefining aesthetic medicine through regenerative innovation that spans dermal fillers to large-volume enhancements.
Investors
A Transformational Opportunity in Regenerative Medicine
Growing Market Demand.
The global shift toward safer, natural aesthetic and reconstructive solutions continues to expand.
Provisional Science.
Supported by preclinical, peer-reviewed data, Conexeu’s patented collagen approach is being investigated for applications ranging from facial rejuvenation to large-volume body contouring.
Seasoned Leadership.
World-renowned aesthetic surgeon, tissue-engineering PhDs, former CEOs/CMOs of global aesthetics leaders & medical device veterans with proven FDA-clearance track records.
“Join Us in Shaping the Future of Regenerative Medicine”
At Conexeu, we’re not just introducing another filler or graft; we’re igniting a paradigm shift in how medicine approaches tissue restoration. From investors seeking high-growth opportunities to clinicians pursuing safer and more effective therapies—everyone benefits from a future driven by true regeneration.
Find Out More
Join our newsletter for regular updates on our progress.
"*" indicates required fields